Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
In patients with heart failure and mildly reduced or preserved ejection fraction, finerenone resulted in a significantly lower rate of a composite of total worsening heart failure events and death from cardiovascular causes than placebo. (Funded by Bayer; FINEARTS-HF ClinicalTrials.gov number, NCT04435626.).
Authors
- Eva Gonçalvesová (ORCID: https://orcid.org/0000-0001-9969-6738)
- Sorel Goland (ORCID: https://orcid.org/0000-0002-5821-1113)
- Sanjiv J. Shah (ORCID: https://orcid.org/0000-0002-5655-8201)
- Clara Saldarriaga (ORCID: https://orcid.org/0000-0002-5945-1127)
- Mark C. Petrie (ORCID: https://orcid.org/0000-0002-6333-9496)
- Dirk von Lewinski (ORCID: https://orcid.org/0000-0001-9996-6128)
- Mareev VIu (ORCID: https://orcid.org/0000-0002-7285-2048)
- Cândida Fonseca (ORCID: https://orcid.org/0000-0003-3019-5956)
- José Francisco Kerr Saraiva (ORCID: https://orcid.org/0000-0003-3345-8862)
- Changsheng Ma (ORCID: https://orcid.org/0000-0002-5387-5957)
- Heikki Ukkonen (ORCID: https://orcid.org/0000-0002-2931-3073)
- Orly Vardeny (ORCID: https://orcid.org/0000-0002-6387-1351)
- Johann Bauersachs (ORCID: https://orcid.org/0000-0002-9341-117X)
- Pardeep S. Jhund (ORCID: https://orcid.org/0000-0003-4306-5317)
- Guillermo Llamas-Esperón
- Gerasimos S Filippatos (ORCID: https://orcid.org/0000-0002-5640-0332)
- Grzegorz Gajos (ORCID: https://orcid.org/0000-0002-7361-3559)
- James Lay‐Flurrie
- John J.V. McMurray (ORCID: https://orcid.org/0000-0002-6317-3975)
- Marco Antonio Alcocer-Gamba (ORCID: https://orcid.org/0000-0003-2033-2494)
- Morten Schou (ORCID: https://orcid.org/0000-0002-4271-2466)
- Alasdair Henderson (ORCID: https://orcid.org/0000-0002-8903-4906)
- Felipe A. Martínez (ORCID: https://orcid.org/0000-0002-5836-972X)
- Faiez M. Zannad (ORCID: https://orcid.org/0000-0001-7456-1570)
- Gerard C.M. Linssen (ORCID: https://orcid.org/0000-0002-3339-1955)
- Bertram Pitt (ORCID: https://orcid.org/0000-0001-5880-275X)
- Brian Claggett
- Peter Kolkhof (ORCID: https://orcid.org/0000-0003-3425-7528)
- Mikhail Kosiborod (ORCID: https://orcid.org/0000-0002-3750-9789)
- Scott David Solomon (ORCID: https://orcid.org/0000-0003-3698-9597)
- Richard W. Troughton (ORCID: https://orcid.org/0000-0001-7484-4036)
- John James Atherton (ORCID: https://orcid.org/0000-0003-2271-578X)
- Savina Nodari (ORCID: https://orcid.org/0000-0002-6650-1735)
- Seok‐Min Kang (ORCID: https://orcid.org/0000-0001-9856-9227)
- Kavita Sharma (ORCID: https://orcid.org/0000-0002-4264-1717)
- Muthiah Vaduganathan (ORCID: https://orcid.org/0000-0003-0885-1953)
- Ovidiu Chioncel (ORCID: https://orcid.org/0000-0002-3197-3628)
- Carolyn S.P. Lam (ORCID: https://orcid.org/0000-0003-1903-0018)
- Imran Zainal Abidin (ORCID: https://orcid.org/0000-0002-3751-6946)
- Gustavs Latkovskis (ORCID: https://orcid.org/0000-0002-1322-7920)
- Vojtěch Melenovský (ORCID: https://orcid.org/0000-0001-8921-7078)
- Tzvetana Katova
- Adriaan A. Voors (ORCID: https://orcid.org/0000-0002-5417-4415)
- Vijay Chopra (ORCID: https://orcid.org/0000-0001-9512-1718)
- Subodh Verma (ORCID: https://orcid.org/0000-0002-4018-8533)
- Shelley R. Zieroth (ORCID: https://orcid.org/0000-0002-6145-9814)
- Chern‐En Chiang (ORCID: https://orcid.org/0000-0002-1151-1047)
- Jacob A. Udell (ORCID: https://orcid.org/0000-0001-7402-9584)
- Л. Г. Воронков (ORCID: https://orcid.org/0000-0002-9339-7427)
- Béla Péter Merkely (ORCID: https://orcid.org/0000-0001-6514-0723)
- Naoki Sato (ORCID: https://orcid.org/0000-0002-5550-0083)
- Ilse van Gameren
- Mehmet Birhan Yılmaz (ORCID: https://orcid.org/0000-0002-8169-8628)
- Alex Pui‐Wai Lee (ORCID: https://orcid.org/0000-0002-4120-155X)
- Akshay S. Desai
- Prabhakar Viswanathan
- Michele Senni
- Josep Comin-Colet
- Flaviana Amarante
Institutions
- British Heart Foundation (GB)
Publication Details
- Journal
- New England Journal of Medicine
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1056/nejmoa2407107
- Citations
- 581
- Primary Topic
- Hormonal Regulation and Hypertension
- Type
- article
- Field-Weighted Citation Impact
- 207.82
Funders
- Bayer